WE BUILD COMPANIES
TO CHANGE THE WORLD


CATEGORIES

All Events
All News
Flywheel
Imbio
Invenshure
OneOme

HEADQUARTERS

  • T

  • 612.506.1234

  • 277 Colfax Avenue North
    Suite 148
    Minneapolis, MN 55405

OneOme announces agreement with ProZed Pharmacy Solutions

PARTNERSHIP IS PERSONALIZED MEDICINE COMPANY’S FIRST ENTRY INTO CANADIAN RETAIL PHARMACY MARKET

Posted July 26, 2017

Minneapolis, Minnesota; North Bay, Ontario (July 26, 2017) – A new partnership between OneOme and ProZed Pharmacy Solutions brings the power of personalized medicine to Canada. Minnesota-based OneOme will provide its RightMed® pharmacogenomics platform exclusively to customers of ProZed Pharmacy Solutions at Northern Shores Pharmacy in North Bay, Ontario as the first step in a nationwide launch. The partnership is the precision medicine company’s first entry into the Canadian retail

Read More…

OneOme Forges Partnership with Total Quality Medicine

Agreement will Bring OneOme’s Pharmacogenomic Testing to Patients in Mexico

Posted July 13, 2017

MINNEAPOLIS, MEXICO CITY (July 13, 2017) – Pharmacogenomics leader OneOme today announced it has forged a partnership with Mexico City-based Total Quality Medicine (TQM). The agreement will bring OneOme’s pharmacogenomic (PGx) testing and support services to patients in Mexico, as TQM incorporates OneOme’s RightMed PGx test into its GeneTest line of personalized medicine products. OneOme is a Minneapolis-based leader in pharmacogenomic testing and clinical support tools that help physicians customize

Read More…

OneOme Releases Product Updates to Improve Provider Experience

MAKES IMPROVEMENTS TO ORDERING PORTAL, TEST REPORTS AND RIGHTMED ADVISOR TO OPTIMIZE USER EXPERIENCE, EFFECTIVENESS

Posted June 28, 2017

MINNEAPOLIS (June 15, 2017) – OneOme today launched a product update that makes improvements to its RightMed® pharmacogenomic test workflow, report and interactive application. OneOme’s updates incorporate customer feedback to optimize its product, with the goal of bringing the power of pharmacogenomics into everyday clinical care. “OneOme is continually improving our products to fulfill our core mission of making affordable pharmacogenomic testing widely available and clinically relevant,” Paul Owen, CEO

Read More…

OneOme Collaborates on Nation’s Largest Population-Based Pharmacogenomics Study

RIGHT 10K STUDY MEASURES IMPACT OF PHARMACOGENOMICS ON HEALTH AND ECONOMIC OUTCOMES

Posted June 1, 2017

MINNEAPOLIS (May 31, 2017) – Pharmacogenomic company OneOme announced today it is working with leading health institutions on the nation’s largest population-based pharmacogenomics study. Pharmacogenomics is an emerging field that combines the study of how drugs affect our bodies (pharmacology) with the study of our genes and their functions (genomics). The study, developed and led by Mayo Clinic, is called the RIGHT 10K study and its purpose is to examine

Read More…

Women’s Health Week Shines Light on New Area of Personalized Medicine

Posted May 12, 2017

MINNEAPOLIS (May 12, 2017) – National Women’s Health Week (May 14-20) is an important annual reminder for women to prioritize their health. Fortunately, a new area of personalized medicine called pharmacogenomics is helping women avoid and treat many top health issues. OneOme’s RightMed® pharmacogenomic test uses the power of DNA to predict which medications may work best for an individual patient – helping women avoid adverse drug reactions and better

Read More…

OneOme Wins Eureka! Innovation Award

Posted May 12, 2017

MINNEAPOLIS (May 08, 2017) – Minneapolis-based pharmacogenomics company OneOme today announced it has earned a 2017 Eureka Innovation Award from the Minneapolis / St. Paul Business Journal. The Eureka Innovation awards recognize game-changing companies across Minnesota industries. OneOme earned this recognition due to its groundbreaking product that brings routine pharmacogenomic testing into medical clinics around the world, and integrates results into the patient’s medical record for years of more accurate,

Read More…

Precision Medicine Event Features OneOme’s Director of Medical Affairs

MINNESOTA HEALTH CARE ROUNDTABLE TAKES PLACE APRIL 20TH FROM 1-4 P.M.

Posted May 12, 2017

MINNEAPOLIS (April 19, 2017) – Tomorrow, OneOme’s director of medical affairs Josiah Allen will join the Minnesota Health Care Roundtable on precision medicine. The panel, which includes local leaders in the field, takes place on Thursday, April 20, from 1 to 4 p.m. at the Downtown Minneapolis Hilton and Towers. The roundtable discussion aims to explore how technological and policy advancements can promote more precise medical treatments to improve health.

Read More…

Right the first time: How a Minneapolis company uses DNA tests to limit the side effects of psychiatric meds

Posted April 5, 2017

MinnPost published an article recounting the story of how OneOme’s RightMed pharmacogenomic test helped identify an effective prescription treatment for a teenager struggling with mental health conditions. For 10 years Carly and her family searched for the right medications and doses for her anxiety, ADHD, and depression. This process caused adverse drug reactions that had mentally and physically debilitating effects on Carly’s childhood. When she was 17 years old, her

Read More…

OneOme Receives Laboratory Clinical Certification from Five States

RIGHTMED TEST MITIGATES BARRIERS FOR IMPLEMENTING PHARMACOGENOMICS

Posted April 4, 2017

MINNEAPOLIS (March 27, 2017) – Pharmacogenomics company OneOme today announced the results of its clinician pharmacogenomic testing awareness survey. OneOme will formally share its findings at the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting, which begins March 27 in Denver. OneOme’s poster, Strategies for increasing clinician awareness of pharmacogenomic testing, will be presented on March 28, 2017 from 5:45-7:30 p.m. The study, conducted by

Read More…

OneOme Shares Findings of Pharmacogenomics Awareness Survey

RIGHTMED TEST MITIGATES BARRIERS FOR IMPLEMENTING PHARMACOGENOMICS

Posted April 3, 2017

MINNEAPOLIS (March 27, 2017) – Pharmacogenomics company OneOme today announced the results of its clinician pharmacogenomic testing awareness survey. OneOme will formally share its findings at the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting, which begins March 27 in Denver. OneOme’s poster, Strategies for increasing clinician awareness of pharmacogenomic testing, will be presented on March 28, 2017 from 5:45-7:30 p.m. The study, conducted by

Read More…